Measures to summarize and compare the predictive capacity of markers

International Journal of Biostatistics

Volumn 5, Issue 1, 2009, Pages

  Gu, Wen ^a   Pepe, Margaret ^b  

^a University of Washington ^*

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Classification; Decision making; Discrimination; Risk

Indexed keywords

ARTICLE; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; CYSTIC FIBROSIS; DECISION MAKING; HEALTH CARE PERSONNEL; HUMAN; LUNG FUNCTION; LUNG INFECTION; NUTRITIONAL STATUS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL MODEL; COMPUTER SIMULATION; METHODOLOGY; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RISK;

BIOLOGICAL MARKER;

BIOLOGICAL MARKERS; COMPUTER SIMULATION; HUMANS; MODELS, STATISTICAL; PREDICTIVE VALUE OF TESTS; RESEARCH DESIGN; RISK; ROC CURVE;

EID: 70350457746     PISSN: 15574679     EISSN: None     Source Type: Journal    
DOI: 10.2202/1557-4679.1188     Document Type: Article

References (42)

1. Baker, S.G., Kramer, B.S. and Srivastava, S. (2002), Markers for Early Detection of Cancer: Statistical Guidelines for Nested Case-Control Studies, BMC Medical Research Methodology, 2, 4.
2. Bura, E. and Gastwirth, J. L. (2001), The Binary Regression Quantile Plot: Assessing the Importance of Predictors in Binary Regression Visually, Biometrical Journal, 43, 5-21.
3. Cook, N.R. (2007), Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction, Circulation, 115, 928-935.
4. Cook, N.R., Buring, J.E. and Ridker, P.M. (2006), The E.ect of Including CReactive Protein in Cardiovascular Risk Prediction Models for Women, Annals of Internal Medicine, 145, 21-29.
5. D'Agostino Sr., R.B., Vasan, R.S., Pencina, M.J., Wolf, P.A., Cobain, M., Massaro, J.M. and Kannel, W.B. (2008), General Cardiovascular Risk Pro.le for Use in Primary Care: The Framingham Heart Study, Circulation, 117, 743-753.
6. Expert Panel on Detection EaToHBCiA. (2001), Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), The Journal of the American Medical Association, 285(19), 2486-2497.
7. Gail, M.H. and Pfei.er, R.M. (2005), On Criteria for Evaluating Models of Absolute Risk, Biostatistics, 6(2), 227-239.
8. Green, D.M. and Swets, J.A. (1996), Signal detection theory and psychophysics. New York: Wiley.
9. Gu, W. and Pepe, M.S. (2009), Estimating the Capacity for Improvement in Risk Prediction with a Marker, Biostatistics, 10(1), 172-186.
10. Gu, W. and Pepe, M.S. (2009a), Measures to Summarize and Compare the Predictive Capacity of Markers, UW Biostatistics Working Paper Series, Working Paper 342.
11. Hamill, P.V., Drizd, T.A., Johnson, C.L., Reed, R.B. and Roche, A.F. (1977), NCHS Growth Curves for Children Birth-8 Years, United States, Vital Health Statistics 11, pp. 1-74. Washington, DC.
12. Hosmer, D.W. and Lemeshow, S. (1989), Applied Logistic Regression (section 5.2.2). New York: Wiley.
13. Hu, B., Palta, M. and Shao, J. (2006), Properties of R2 Statistics for Logistic Regression, Statistics in Medicine, 25(8), 1383-1395.
14. Huang, Y. and Pepe, M.S. (2008a), Semiparametric and Nonparametric Methods for Evaluating Risk Prediction Markers in Case-Control Studies, UW Biostatistics Working Paper Series, Working Paper 333.
15. Huang, Y. and Pepe, M.S. (2008b), A Parametric ROC Model Based Approach for Evaluating the Predictiveness of Continuous Markers in Case- Control Studies, Biometrics, doi: 10.1111/j.1541-0420.2005.00454.x
16. Huang, Y., Pepe, M.S. and Feng, Z. (2007), Evaluating the Predictiveness of a Continuous Marker, Biometrics, 63(4), 1181-1188.
17. Hunink, M., Glasziou, P., Siegel, J., Weeks, J., Pliskin, J., Elstein, A. and Weinstein, M. (2006), Decision making in health and medicine. Cambridge University Press.
18. Janes, H., Pepe, M.S. and Gu, W. (2008), Assessing the Value of Risk Predictions Using Risk Strati.cation Tables, Annals of Internal Medicine, 149(10), 751-760.
19. Janssens, A.C.J.W., Aulchenko, Y.S., Elefante, S., Borsboom, G.J.J.M, Steyerberg, E.W. and van Duijn, C.M. (2006), Predictive Testing for Complex Diseases Using Multiple Genes: Fact or Fiction?, Genetics in Medicine, 8(7), 395-400.
20. Knudson, R.J., Lebowitz, M.D., Holberg, C.J. and Burrows, B. (1983), Changes in the Normal Maximal Expiratory Flow-Volume Curve with Growth and Aging, The American Review of Respiratory Disease, 127, 725-734.
21. Pencina, M.J., D'Agostino Sr., R.B., D'Agostino Jr., R.B. and Vasan, R.S. (2008), Evaluating the Added PredictiveAbility of a NewMarker: From Area Under the ROC Curve to Reclassi.cation and Beyond, Statistics in Medicine, 27, 157-172.
22. Pepe, M.S. (2003), The Statistical Evaluation of Medical Tests for Classi.cation and Prediction. Oxford University Press.
23. Pepe, M.S., Etzioni, R., Feng, Z., Potter, J.D., Thompson, M.L., Thornquist, M.,Winget, M. and Yasui, Y. (2001), Phases of Biomarker Development for Early Detection of Cancer, Journal of the National Cancer Institute, 93, 1054061.
24. Pepe, M.S., Feng, Z. and Gu, W. (2008b), Comments on 'Evaluating the Added Predictive Ability of a New Marker: From Area Under the ROC Curve to Reclassi.cation and Beyond', Statistics in Medicine, 27, 173-181.
25. Pepe, M.S., Feng, Z., Huang, Y., Longton, G.M., Prentice, R., Thompson, I.M. and Zheng, Y. (2008a), Integrating the Predictiveness of a Marker with its Performance as a Classi.er, American Journal of Epidemiology, 167(3), 362-368.
26. Pepe, M.S. and Janes, H. (2008c), Gauging the Performance of SNPs, Biomarkers and Clinical Factors for Predicting Risk of Breast Cancer, Journal of the National Cancer Institute, 100(14), 978-979.
27. Pepe, M.S., Feng Z, Janes H, Bossuyt P and Potter J. (2008d), Pivotal Evaluation of the Accuracy of a Biomarker Used for Classi.cation or Prediction: Standards for Study Design, Journal of the National Cancer Institute, 100(20), 1432-1438.
28. Pepe, M.S., Janes, H. and Gu, W. (2007), Letter by Pepe et al Regarding the Article, 'Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction', Circulation, 116, e132.
29. Prentice, R.L. and Pyke, R. (1979), Logistic Disease Incidence Models and Case-Control Studies, Biometrika, 66(3), 403-411.
30. Qin, J. (1998), Inferences for Case-Control and Semiparametric Two-Sample Density Ratio Models, Biometrika, 85(3), 619-630.
31. Qin, J. and Lawless, J. (1994), Empirical Likelihood and General Estimating Equations, The Annals of Statistics, 66(3), 403-411.
32. Qin, J. and Zhang, B. (1997), A goodness of .t test for logistic regression models based on case-conrol data, Biometrika, 84(3), 609-618.
33. Qin, J. and Zhang, B. (2003), Using logistic regression procedures for estimating receiver operating characteristic curves, Biometrika, 90(3), 585-596.
34. Ransoho., D.F. (2004), Rules of Evidence for Cancer Molecular-Marker Discovery and Validation, Nature Reviews Cancer, 4(4), 309-314.
35. Ridker, P.M., Hennekens, C.H., Buring, J.E. and Rifai, N. (2000), C-Reactive Protein and Other Markers of In.ammation in the Prediction of Cardiovascular Disease in Women, New England Journal of Medicine, 342, 836-843. (Pubitemid 30165206)
36. Ridker, P.M., Paynter, N.P., Rifai, N., Gaziano, J.M. and Cook, N.R. (2008), C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Risk Score for Men, Circulation, 118, 2243-2251.
37. Simon, R. (2006), Roadmap for Developing and Validating Therapeutically Relevant Genomic Classi.ers, Journal of Clinical Oncology, 23(29), 7332-7341.
38. Stern, R.H. (2008), Evaluating New Cardiovascular Risk Factors for Risk Strati.cation, The Journal of Clinical Hypertension, 10(6), 485-488.
39. Vickers, A.J. and Elkin, E.B. (2006), Decision Curve Analysis: a Novel Method for Evaluating Prediction Models, Medical Decision Making, 26(6), 565-574.
40. Ware, J.H. and Cai T. (2008), Comments on 'Evaluating the Added Predictive Ability of a New Marker: From Area Under the ROC Curve to Reclassi.cation and Beyond', Statistics in Medicine, 27, 185-187.
41. Youden, W.J. (1950), Index for Rating Diagnostic Tests, Cancer, 3, 325.
42. Zheng, B and Agresti, A. (2000), Summarizing the Predictive Power of a Generalized Linear Model, Statistics in Medicine, 19(13), 1771-1781.